Syros Pharmaceuticals is based in Cambridge, MA. It has raised $123M in total funding. Backed by Deerfield Management, Fidelity, WuXi Healthcare Ventures.
Syros Pharmaceuticals funding overview
Syros Pharmaceuticals is based in Cambridge, MA. Syros Pharmaceuticals has raised $123M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Syros Pharmaceuticals runs through 2016; nothing later has been disclosed. Investors on record include Deerfield Management, Fidelity, WuXi Healthcare Ventures, Polaris Partners, Redmile, Aisling Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Syros Pharmaceuticals funding
How much has Syros Pharmaceuticals raised?
Syros Pharmaceuticals has raised $123M in total disclosed funding across the rounds on record.
Who has invested in Syros Pharmaceuticals?
Deerfield Management, Fidelity, WuXi Healthcare Ventures, Polaris Partners, Redmile, Aisling Capital are named among the investors backing Syros Pharmaceuticals.
What was the latest Syros Pharmaceuticals funding round?
No round stage has been disclosed for Syros Pharmaceuticals.
Where is Syros Pharmaceuticals based?
Syros Pharmaceuticals is based in Cambridge, MA.
When did Syros Pharmaceuticals last raise?
The last disclosed Syros Pharmaceuticals round closed in January 2016.
Syros Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
